Protein tyrosine phosphatase (PTP) is a receptor type protein tyrosine phosphatase that uses pleiotrophin as a ligand. Pleiotrophin inactivates the phosphatase activity of PTP, resulting in the increase of tyrosine phosphorylation levels of its substrates. We studied the functional interaction between PTP and DNER, a Notch-related transmembrane protein highly expressed in cerebellar Purkinje cells. PTP and DNER displayed patchy colocalization in the dendrites of Purkinje cells, and immunoprecipitation experiments indicated that these proteins formed complexes. Several tyrosine residues in and adjacent to the tyrosine-based and the second C-terminal sorting motifs of DNER were phosphorylated and were dephosphorylated by PTP, and phosphorylation of these tyrosine residues resulted in the accumulation of DNER on the plasma membrane. DNER mutants lacking sorting motifs accumulated on the plasma membrane of Purkinje cells and Neuro-2A cells and induced their process extension. While normal DNER was actively endocytosed and inhibited the retinoic-acid-induced neurite outgrowth of Neuro-2A cells, pleiotrophin stimulation increased the tyrosine phosphorylation level of DNER and suppressed the endocytosis of this protein, which led to the reversal of this inhibition, thus allowing neurite extension. These observations suggest that pleiotrophin-PTP signaling controls subcellular localization of DNER and thereby regulates neuritogenesis.
Protein tyrosine phosphatase (PTP), also known as RPTP/␤, is a receptor type protein tyrosine phosphatase that is synthesized as a chondroitin sulfate proteoglycan (12, 16, 17, 21, 28, 32) . There are three major splice variants of this molecule, the full-length form (PTP-A), the short receptor form (PTP-B), and the secreted form (phosphacan) ( Fig. 1) (28) . PTP uses two highly related heparin-binding growth factors, pleiotrophin (PTN) and midkine, as ligands (14, 22-24, 29, 35) . PTN has been shown to suppress the tyrosine phosphatase activity of PTP by inducing receptor dimerization (10, 29) .
PTP-PTN signaling has been shown to control neurite extension and cell migration processes probably through the regulation of cytoskeletal dynamics (22, 23, 31, 32) . Although several downstream targets of PTP such as ␤-catenin, GIT1/ cat-1, and ␤-adducin have been identified (14, 29, 33) , the regulatory mechanism of neuritogenesis by PTP-PTN signaling is largely unknown.
We previously demonstrated that PTP-PTN signaling is involved in the morphogenesis of cerebellar Purkinje cell dendrites (40, 43) . By inhibiting the PTP-PTN signaling, aberrant morphogenesis of Purkinje cell dendrites such as multiple and disoriented primary dendrites was induced in a slice culture system (43) . In addition, the expression of GLAST, a glial glutamate transporter, in Bergmann glia was also suppressed by the inhibition of PTP signaling (43) . During development, the dendritic arbors of Purkinje cells elongate in close association with the radial processes of Bergmann glia, and the lamellate processes of Bergmann glia also wrap around the cell bodies and dendrites of Purkinje cells, suggesting that cell-cell interaction between these cells plays important roles in their development (19, 46) . Immunohistochemical studies indicated that PTN and phosphacan/PTP were deposited in the space between Purkinje cells and the adjacent processes of Bergmann glia, which suggested that PTP-PTN signaling mediates the interaction between Purkinje cells and Bergmann glia regulating the differentiation of both types of cells (40) .
On the other hand, we recently identified Delta/Notch-like epidermal growth factor (EGF)-related receptor (DNER) (7), a single-pass transmembrane protein with 10 EGF-like repeats in the extracellular domain, which is highly expressed in Purkinje cells (Fig. 1) . DNER acts as a ligand of Notch expressed by Bergmann glia and regulates the development of the cerebellar cortex, including the morphogenesis and maturation of Bergmann glia and synapse formation between Purkinje cells and climbing fibers (8, 44) . Thus, DNER-Notch signaling plays critical roles in the Purkinje cell-Bergmann glia interaction.
The short cytoplasmic region of DNER contains a tyrosinebased sorting motif, YXX⌽ (where X and ⌽ represent any amino acid and a bulky hydrophobic residue, respectively), and the C-terminal tail with a dileucine motif. The tyrosine-based motif has been shown to be required for dendritic targeting of DNER from the trans-Golgi network and endocytosis of this protein from the plasma membrane (7) . In this study, we in-vestigated the possibility that PTP regulates the DNER activity by controlling the tyrosine phosphorylation levels of the DNER cytoplasmic domain. We demonstrate here that the tyrosine residues in and adjacent to the sorting motifs of DNER are phosphorylated, which leads to the accumulation of this protein on the plasma membrane. Accumulation of DNER on the plasma membrane results in the promotion of neurite extension. PTP associates with DNER and can dephosphorylate this receptor, raising the possibility that PTP-PTN signaling controls the subcellular localization of DNER in neurons and thereby regulates neuritogenesis. Various neurons such as hippocampal and cortical neurons express both DNER and PTP (7, 42) , raising the possibility that this mechanism regulates neuritogenesis in many brain areas.
MATERIALS AND METHODS
Animals. BALB/c mice were purchased from SLC Inc. (Shizuoka, Japan). All the animal experiments were performed with the approval of the Animal Use and Care Committee of the Tokyo Metropolitan Institute for Neuroscience.
Immunohistochemistry. After ether anesthesia, BALB/c mice were perfused with 4% paraformaldehyde (PFA) in 0.1 M sodium phosphate buffer, pH 7.4. The brains were dissected and postfixed for 4 h in the same solution. The tissues were cryoprotected in 30% sucrose in 0.1 M sodium phosphate buffer, pH 7.4, and frozen with liquid nitrogen. The 30-m-thick sagittal sections were cut with a cryostat (CM1900; Leica, Houston, TX). The cryosections were treated with 25 mM glycine in phosphate-buffered saline (PBS) for 20 min and washed with 0.3% Triton X-100 in PBS (PBST). The sections were blocked with 5% normal goat serum (NGS) in PBST overnight at 4°C and then incubated with anti-PTP (catalog no. 610180; BD Bioscience, San Jose, CA) (1:40) and anti-DNER (7) (1:500) antibodies diluted in 5% NGS-PBST for 3 days at 4°C under free-floating conditions. After being washed with PBST, sections were incubated with Alexa Fluor 488 goat anti-mouse immunoglobulin G (IgG; Invitrogen, Carlsbad, CA) (1:500) and Alexa Fluor 594 goat anti-rabbit IgG (1:500) diluted in 5% NGS-PBS for 2 h. After being washed with PBST, the sections were observed under a confocal laser scanning microscope (FV-1000; Olympus, Tokyo, Japan) using UplanSApo 60ϫ numerical aperture (NA) 1.42 oil and UplanSApo 100ϫ NA 1.40 oil lenses. Results were then processed for publication using Adobe Photoshop 7.0 software (Adobe Systems, Inc., San Jose, CA) with minimal adjustments of brightness and contrast applied to the whole images.
Electron microscopy. BALB/c mice were perfused with 4% PFA containing 0.05% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4. The brains were dissected and postfixed for 4 h in the same solution. The 50-m-thick sagittal sections were cut on a vibratome (DTK-3000W; Dosaka Co., Kyoto, Japan). The sections were blocked with 4% NGS, 2% bovine serum albumin (BSA), 0.02% Triton X-100 in PBS for 1 h. They were incubated with anti-PTP (1:40) or anti-DNER (1:200) antibodies in 1% BSA-PBS for 2 days at 4°C. The sections were incubated with biotinylated anti-mouse IgG (GE Healthcare, Buckinghamshire, England) (1:200) or anti-rabbit IgG (1:200) diluted in PBS for 1 h and then processed using a Vectastain ABC kit (Vector Laboratories, Burlingame, CA). They were then treated with 0.02% 3,3Ј-diaminobenzidine-0.02% hydrogen peroxide-50 mM Tris-HCl, pH 7.6. The sections were postfixed with 2% OsO 4 in 0.1 M sodium phosphate buffer, pH 7.4, for 45 min; dehydrated using an alcohol series and propylene oxide; and flat embedded in epoxy resin (Quetol 812; Nisshin EM Co., Tokyo, Japan). Ultrathin sections were cut with an ultramicrotome (MT-7000 XL; RMC Products, Tucson, AZ), mounted on Formvarcoated copper grids, and stained with uranyl acetate. Observations were made using a Hitachi H7500 electron microscope (Tokyo, Japan) at 80 kV.
Cell culture, transfection, and immunocytochemistry. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Sigma, St. Louis, MO) supplemented with 10% fetal bovine serum (FBS) (Invitrogen) at 37°C under 5% CO 2 . Transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The coding regions of PTP-A and PTP-B (32) were ligated into pcDNA3.1 expression vector (Invitrogen). Full-length DNER and the cytoplasmic domain deletion mutant (DdI) cDNAs were hemagglutinin (HA) epitope tagged by being subcloned into the pDisplay expression vector as VOL. 28, 2008 ASSOCIATION OF PTP WITH DNER 4495 previously described (7, 8) . Point mutant constructs of DNER were generated by PCR using a full-length construct as template. Cells were fixed with 4% PFA in PBS for 20 min and permeabilized with 0.1% Triton X-100 in PBS for 10 min. Cells were blocked with 4% NGS-2% BSA-PBS for 30 min and incubated with primary antibodies diluted in 1% BSA-PBS overnight at 4°C. Cells were incubated with Alexa Fluor secondary antibodies diluted in 1% BSA-PBS (1:500) for 30 min. Samples were observed under an FV-1000 confocal laser scanning microscope using a UplanSApo 100ϫ NA 1.40 oil objective lens, and the results were processed as described above.
Immunoprecipitation and immunoblotting. The cerebella were homogenized in 15 volumes of buffer A (0.1 mM phenylmethylsulfonyl fluoride-10 M pepstatin A-10 M leupeptin-2 mM sodium vanadate-10 mM sodium fluoride-1 mM sodium pyrophosphate-1 mM EDTA-50 mM Tris-HCl, pH 7.3) containing 0.32 M sucrose. The homogenates were centrifuged at 1,000 ϫ g for 5 min at 2°C, and the resultant supernatants (S1 fraction) were used for Western blot analysis using anti-DNER and anti-6B4PG (21) to detect DNER and phosphacan, respectively, as described previously (20, 22) . They were also analyzed using antiactin antibody (A 2066; Sigma). To detect PTP and tyrosine-phosphorylated DNER, the S1 fraction was further centrifuged at 100,000 ϫ g for 1 h at 2°C, and the resultant precipitates were solubilized with 1% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate}-0.15 M NaCl-buffer A. The lysates were subjected to immunoprecipitation using anti-6B4PG and anti-DNER and analyzed by Western blotting using anti-PTP or antiphosphotyrosine antibody 4G10 (Upstate Biotechnology, Lake Placid, NY) as described previously (32) . Detection of immunoreactive bands was performed using an ECL Plus kit (GE Healthcare).
COS-7 transfectants were solubilized with buffer B (0.15 M NaCl-20 mM HEPES-NaOH, pH 7.4-2 mM CaCl 2 -2 mM MgCl 2 -protease inhibitor cocktail [1:50; Nacalai Tesque, Kyoto, Japan]) containing 1% Nonidet P-40 (NP-40), and the solutions were centrifuged at 17,400 ϫ g for 10 min at 4°C. The supernatants were incubated with 5 g/ml of anti-6B4PG or anti-HA polyclonal antibody (Sigma) for 2 h at 4°C and further incubated for 60 min after addition of 25 l of protein G Sepharose 4FF (GE Healthcare). Normal rabbit IgG (Dako, Carpinteria, CA) was used as control. Immunoprecipitates were washed three times with 0.2% NP-40-buffer B and then washed once with PBS containing 0.9 mM CaCl 2 and 0.33 mM MgCl 2 . The immunoprecipitates were then incubated with 10 mU/ml protease-free chondroitinase ABC (Seikagaku, Tokyo, Japan) in the buffer containing 10 mM Tris-HCl, pH 7.4, 3 mM sodium acetate, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 0.1 mM pepstatin A for 15 min at 37°C. The proteins were separated by 5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by Western blotting with anti-HA monoclonal antibody 12CA5 (Roche, East Sussex, United Kingdom) or anti-6B4PG antibody by using an ECL Plus Western blotting kit.
Cerebella from P7 rats were mixed with 10 volumes of the solution containing 0.32 M sucrose, 2 mM CaCl 2 , 2 mM MgCl 2 , 50 mM Tris-HCl, pH 7.3, and protease inhibitor cocktail (1:50) and homogenized in a glass-Teflon Potter homogenizer with 10 strokes at 850 rpm. The homogenates were centrifuged at 1,000 ϫ g for 5 min at 4°C, and the resultant supernatants were centrifuged at 100,000 ϫ g for 60 min at 4°C. The precipitates were mixed with 1% NP-40-buffer B and gently stirred for 60 min on ice. After centrifugation at 15,000 ϫ g for 10 min at 4°C, the supernatants were preadsorbed with protein G Sepharose 4FF by rotating the sample tubes for 2 h at 4°C. After brief centrifugation, the supernatants were subjected to immunoprecipitation using anti-DNER as described above. The immunoprecipitates were analyzed by Western blotting using anti-6B4PG to detect the association of PTP/phosphacan and DNER.
In vitro dephosphorylation assay. Glutathione S-transferase (GST)-tagged tyrosine phosphatase catalytic domain of rat PTP (0.34 U/g; amino acid residues 1675 to 2021) was expressed in Escherichia coli using pGEX-6P-2 vector (GE Healthcare) and purified by using a glutathione-Sepharose 4B column. The phosphatase activities were measured using p-nitrophenyl phosphate as described previously (21) . One unit is defined as the activity which releases 1 nmol of phosphate per min.
COS-7 cells transfected with DNER constructs were cultured in the presence of 100 M sodium vanadate for 12 h. The cells were solubilized in buffer C (0.15 M NaCl-20 mM HEPES-NaOH, pH 7.3-5 mM EDTA-2 mM sodium vanadate-5 mM sodium fluoride-10 mM sodium pyrophosphate-protease inhibitor cocktail [1:50] ) containing 1% NP-40 and clarified by centrifugation. HA-tagged DNER was immunoprecipitated using anti-HA polyclonal antibody coupled to protein G Sepharose beads, which were washed once with 0.2% NP-40-buffer C and four times with PTP buffer (40 mM imidazole, pH 7.2-0.1 g/ml BSA-2 mM dithiothreitol). The immunocomplexes were incubated with 0.4 U of GST-tagged tyrosine phosphatase catalytic domain in 25 l of PTP buffer at 30°C. At the times indicated, the reactions were stopped by adding SDS-PAGE sample buffer, and the samples were boiled for 3 min. Samples were separated by 7.5% SDS-PAGE and analyzed by Western blotting using antiphosphotyrosine antibody 4G10.
Biotinylation of cell surface proteins. The cells were washed with ice-cold PBS twice and incubated with 0.5 mg/ml biotin-X-N-hydroxysuccinimide (Calbiochem, La Jolla, CA) dissolved in a borate buffer (10 mM boric acid, 150 mM NaCl, pH 8.0) for 1 h at 4°C. The cells were washed with ice-cold PBS containing 15 mM glycine to terminate biotin coupling and then washed with ice-cold PBS twice. The cells were solubilized in 1% NP-40-buffer C, and the solutions were clarified by centrifugation. The biotinylated proteins were separated using streptavidin agarose (Invitrogen) and analyzed by Western blotting as described above. Quantification by densitometry was done using an Epson GT-9700 scanner (Tokyo, Japan) and Lane Analyzer version 3 software (Atto, Tokyo, Japan).
Organotypic slice culture of cerebellum and biolistic transfection. The methods for slice culture have been described previously (8) . In brief, the vermes of the P9 mouse cerebella were cut parasagittally into 370-m-thick slices in icecold Hanks' balanced salt solution containing 20 mM glucose. The slices were mounted on a 3.0-m porous polycarbonate membrane (Whatman, Maidstone, United Kingdom) that was floated on culture medium in a petri dish. Cerebellar slices were transfected by using a particle-mediated gene transfer device according to the manufacturer's protocols (Helios; Bio-Rad, Hercules, CA) 2 to 5 h after slice preparation. Twenty-five milligrams of 1.0-m gold particles (BioRad) was coated with 30 g of pCA-enhanced green fluorescent protein (EGFP) construct (a kind gift from Y. Shima) with or without DdI construct mixed at 1:5. The plasmid-coated particles were delivered with a rapid helium burst of 1.0 MPa to slices that were covered with nylon mesh (70-m thread spacing; BD Falcon, Bedford, MA) to avoid physical damage. Three days after transfection, cultures were fixed, incubated in 30% sucrose in PBS, and mounted in Crystal/ Mount (Biomeda Co., Foster City, CA). The morphology of Purkinje cells visualized by EGFP expression was analyzed with a Zeiss LSM5 Pascal confocal laser scanning microscope using a Plan-Neofluar, 40ϫ NA 1.3 objective lens.
Analysis of the internalization of DNER. Neuro-2A cells transfected with DNER constructs were washed with ice-cold DMEM and then incubated with 10 g/ml polyclonal rabbit anti-HA antibody in DMEM for 30 min on ice. After being washed with ice-cold DMEM, cells were incubated in DMEM in the presence or absence of 500 ng/ml PTN (R&D Systems, Minneapolis, MN) at 37°C for various periods. Internalization was stopped by adding ice-cold PBS. The cells were fixed with 4% PFA-PBS, permeabilized with 0.1% Triton X-100-PBS, and incubated with Alexa Fluor 488 goat anti-rabbit IgG (1:500). After being washed with PBS, cells were observed under an FV-1000 confocal laser scanning microscope using a UplanSAapo 40ϫ NA 0.90 objective lens. Each experiment was independently repeated three times, and at least 100 cells per experiment were analyzed for each condition. All statistical analyses were performed with the t test.
PTN-coated bead assay. Latex beads (particle diameter, 3 m; Sigma) were coated with 50 g/ml PTN for 24 h at 4°C and then washed three times with PBS. Neuro-2A cells transfected with DNER constructs were serum starved by culturing them in DMEM containing 0.5% FBS for 18 h and then were stimulated with PTN-coated latex beads for various periods. The cells were solubilized in 1% NP-40-buffer C and subjected to immunoprecipitation as described above. Samples were separated by 7.5% SDS-PAGE and analyzed by Western blotting using anti-HA and antiphosphotyrosine antibody 4G10.
Morphological analysis. Twenty-four-well plates were coated with 50 g/ml PTN for 24 h at 4°C and then washed three times with PBS. Neuro-2A cells transfected with mock or DNER constructs were seeded at a density of 2 ϫ 10 4 cells/cm 2 onto PTN-coated 24-well plates and incubated in DMEM containing 5% FBS and 40 M retinoic acid (Sigma) for 24 h. Transfected cells were identified by immunocytochemistry using anti-HA antibody. Samples were analyzed with a combined differential interference contrast and fluorescence microscope (Axiovert 135; Carl Zeiss, Jena, Germany) using a Plan-Neofluoar 20ϫ NA 0.5 objective lens. Images were acquired with a charge-coupled device camera (Sensyl 1401; Photometrics, Tucson, AZ) operated with MetaMorph software (Molecular Devices, Union City, CA). Neurites were defined as thin protrusions of at least one cell diameter in length. Each experiment was independently repeated three times, and at least 100 cells per experiment were analyzed for each condition. Neurite length was measured by manual tracking of neurites using ImageJ (National Institutes of Health, Bethesda, MD). All statistical analyses were performed using the one-way analysis of variance (ANOVA) and Fisher's protected least significant difference post hoc test built into StatView 5.0 (SAS Institute Inc., Cary, NC). 
RESULTS
Developmental expression of PTP and DNER in the cerebellum. To examine the developmental expression of PTP and DNER, we performed immunoblot analysis using mouse cerebella. Before chondroitinase ABC digestion, PTP-A and -B were detected as smears on the immunoblots by using monoclonal antibody against the intracellular domain of PTP, anti-PTP ( Fig. 2A, left) . After chondroitinase ABC digestion, however, sharp 380-and 220-kDa bands were detected ( Fig.  2A, a and b) , which correspond to PTP-A and PTP-B, respectively (32), indicating that both molecules were expressed as chondroitin sulfate proteoglycans. Comparable amounts of PTP-A and PTP-B were detected at postnatal day 6 (P6), and thereafter, the expression of PTP-A was downregulated ( Fig.  2A) . On the other hand, PTP-B was constantly expressed during postnatal cerebellar development ( Fig. 2A) . In addition to these isoforms, a 200-kDa band was detected at each developmental stage ( Fig. 2A, c) . The electrophoretic mobility of this band was not changed after chondroitinase ABC digestion, indicating that it is not a proteoglycan. This might be a nonglycosylated precursor of PTP, although further studies are necessary to reveal this point.
Immunoblotting using antibodies against the extracellular domain of PTP (anti-6B4PG) indicated that phosphacan was abundantly expressed during postnatal development (Fig. 2B) .
DNER showed dynamic changes of expression during cerebellar development. Its expression was upregulated from P6 to P15 and downregulated thereafter (Fig. 2C) . From this finding, we hypothesized that DNER is involved in the dendrite formation of Purkinje cells, which occurs vigorously from P6 to P15 (40) .
Immunohistochemical localization of PTP and DNER in the cerebellum. We next examined the immunohistochemical localization of PTP and DNER by double labeling using anti-DNER and anti-PTP. In the P21 mouse cerebellum, the cell bodies and dendrites of Purkinje cells were clearly stained by anti-DNER (Fig. 3B) . On the other hand, the PTP immunoreactivity was broadly observed in the cerebellar cortex, including the molecular layer, Purkinje cell layer, and granule cell layer (Fig. 3A) . In the molecular layer, the Purkinje cell dendrites were relatively intensely stained by anti-PTP (Fig. 3A) . As revealed by higher-magnification images, both PTP and DNER immunoreactivities showed patchy distribution in the dendritic shafts of Purkinje cells ( Fig. 3D and E) . Merged images revealed that a part of these patches were stained by both the antibodies (Fig. 3F) . It is noteworthy that there was almost no overlapping distribution outside of the thick dendritic shafts of Purkinje cells.
Immunoelectron microscopy indicated that the immunoreactivity to anti-PTP was localized on the cell surfaces of Purkinje cells as patchy stainings and on cytoplasmic vesicles ( Fig.  3G and I ). The staining with anti-PTP was frequently detected on the Purkinje cell surface contacting Bergmann glial processes (Fig. 3G, arrowheads) . The cell surfaces of Bergmann glial processes were also stained by anti-PTP (Fig. 3J) , consistent with the in situ hybridization experiments indicating that both Purkinje cells and Bergmann glia express PTP (42) . The immunoreactivity to anti-DNER was distributed on the plasma membrane of Purkinje cells but not in the Bergmann glial processes (Fig. 3K) . The staining showed patchy distribution and was often observed on the Purkinje cell surface contacting the Bergmann glial processes. In addition, vesicles of various sizes in the Purkinje cell dendrites were stained with anti-DNER (Fig. 3L ). These observations suggest that the patchy colocalization of PTP and DNER immunoreactivities in immunofluorescent microscopy corresponded to the vesicles and/or plasma membrane of Purkinje cells.
FIG. 2. Expression of PTP and DNER in the developing cerebellum. (A)
The extracts of P6, P10, P15, and P20 mice cerebella were subjected to immunoprecipitation using anti-6B4PG, and the immunoprecipitates were analyzed by Western blotting with anti-PTP before (Ϫ CHase) or after (ϩ CHase) chondroitinase ABC digestion. After chondroitinase ABC digestion, the core proteins of 380-kDa PTP-A (a) and 220-kDa PTP-B (b) appeared, indicating that both proteins are synthesized as chondroitin sulfate proteoglycans. The 200-kDa bands (c) were constantly detected during postnatal development; they might be a nonglycosylated PTP precursor. The bands smaller than 150 kDa are nonspecifically stained ones. (B) The expression of phosphacan was examined by Western blotting using anti-6B4PG before or after chondroitinase ABC digestion. The 300-kDa core protein of phosphacan (p) was constantly detected during postnatal development. A minor 150-kDa band was also detected after chondroitinase ABC digestion (u); it might be a degradation product. Numbers at left of panels A and B are molecular masses in kilodaltons. (C) The expression of DNER was examined by Western blotting using anti-DNER. The expression of DNER increased from P6 to P15 and decreased thereafter (d). As a loading control, the blots were reprobed with antiactin antibody.
VOL. 28, 2008 ASSOCIATION OF PTP WITH DNER 4497
Interaction of PTP and DNER. We next examined whether PTP interacts with DNER by immunoprecipitation experiments. Lysates of P7 rat cerebella were subjected to immunoprecipitation experiments using anti-DNER or control rabbit IgG, and the precipitated proteins were analyzed by immunoblotting with anti-6B4PG. After chondroitinase ABC digestion, a faint but significant 300-to 400-kDa band was detected by Western blot analysis of the immunoprecipitates (Fig. 3M) . We could not determine whether this band corresponds to phosphacan or to PTP-A because of the low titer of anti-PTP.
We further investigated the association of PTP and DNER by cotransfection experiments using COS-7 cells. Confocal microscopic analysis of the COS-7 cells transiently expressing PTP-A and DNER tagged with an HA epitope (DHA [ Fig.  1] ) indicated that both proteins were partially colocalized in the intracellular granular compartments, especially around nuclei (Fig. 4A to D) . While PTP-A was detected both on the cell surface and in the intracellular granules, most of the DNER signals showed a punctate pattern at the perinuclear cytoplasm. The COS-7 cells coexpressing PTP-B and DNER showed similar staining patterns (Fig. 4E to H) . In sharp contrast, when a DNER construct lacking most of the intracellular domain (DdI [ Fig. 1 ]) was coexpressed with PTP-A, signals of both proteins were clearly colocalized at the cell surface (Fig.  4I to L) (see Fig. S1 in the supplemental material for quantitative evaluation). We found little intracellular punctate signal. Cotransfectants expressing PTP-B and DdI showed similar cell surface staining ( Fig. 4M to P) .
In spite of such distinct subcellular localizations, PTP was coimmunoprecipitated with both DHA and DdI (Fig. 5) , suggesting that the interaction is mediated by the extracellular and/or transmembrane regions of DNER. In order to examine the possibility of trans interaction, we incubated the DdI transfectants in solutions containing phosphacan (up to 0.2 M) and then stained the cells with anti-6B4PG. However, we observed no significant binding of phosphacan to the cells expressing DdI on the plasma membrane (data not shown). These observations suggest that PTP and DNER interact in a cis manner and that their subcellular localization is regulated by the cytoplasmic region of DNER.
Tyrosine phosphorylation of DNER. The cytoplasmic region of DNER contains a tyrosine-based sorting motif (YXX⌽), which is involved in dendritic targeting of DNER. DNER also contains a C-terminal dileucine type motif, which has been shown to play important roles in polarized targeting and endocytosis of transmembrane proteins (6) . Furthermore, the DNER cytoplasmic region contains several tyrosine residues potentially phosphorylated by tyrosine kinases, including the YXX⌽ motif. Immunoblot analysis of DNER immunoprecipitated from P15 mouse cerebella indicated that this protein was weakly tyrosine phosphorylated in vivo (Fig. 6A) . We next treated the COS-7 transfectants expressing DHA with sodium vanadate, a tyrosine phosphatase inhibitor. The immunoprecipitated DHA from these cells was tyrosine phosphorylated, as revealed by immunoblot analysis using antiphosphotyrosine antibody (Fig. 6B) . We further examined whether DNER can serve as a substrate for PTP. COS-7 transfectants expressing DHA were treated with sodium vanadate, and then the DHA was immunoprecipitated with anti-HA antibody. When the immunoprecipitated tyrosine-phosphorylated DHA was treated with the catalytic domain of PTP, DHA was dephosphorylated (Fig. 6C) .
We noticed that there are four potential tyrosine phosphorylation sites in the cytoplasmic region of DNER: Tyr-677, Tyr-681, Tyr-718, and Tyr-721. Among these sites, Tyr-677 is a part of the tyrosine-based sorting motif, YEE⌽ (Fig. 1B) . The positions of Tyr-718 and -721 are close to the second C-terminal sorting motif (Fig. 1B) . To investigate which tyrosine residues are phosphorylated, we prepared various DNER constructs, in which several of these tyrosine residues were replaced with alanine (Fig. 1B) . COS-7 cells transfected with these DNER constructs were treated with sodium vanadate, and then the tyrosine phosphorylation levels of these mutants were analyzed by immunoblotting (Fig.  6D ). D-Y677A showed a significantly decreased tyrosine phosphorylation level compared with that of the control, DHA, indicating that the tyrosine-based sorting motif itself could be phosphorylated (Fig. 6D) . D-Y677A/Y681A/Y718AAAA showed a further-reduced tyrosine phosphorylation level compared with those of D-Y677A and D-Y677A/Y681A, suggesting that Tyr-718 and/or Tyr-721 could also be phosphorylated (Fig. 6D) . Subcellular localization of DNER regulated by tyrosine phosphorylation. Since it became apparent that an important sorting motif in the cytoplasmic region of DNER is tyrosine phosphorylated, we next investigated whether the subcellular localization of DNER is regulated by tyrosine phosphorylation. As described above, most DHA protein showed intracellular distribution in the COS-7 cells coexpressing DHA and PTP-B (Fig. 7A, a to c) . In contrast, DHA protein accumulated on the cell surface and was colocalized with PTP-B after sodium vanadate treatment (Fig. 7A, d to f) (see Fig. S2 in the supplemental material for a Z-stack image). We next evaluated the presence of DHA protein on the plasma membrane after sodium vanadate treatment by cell surface biotinylation experiments. Western blot analysis clearly indicated that biotinylated cell surface DHA protein was remarkably increased by sodium vanadate in the cells coexpressing DHA and PTP ( Fig. 7B and C) .
Regulation of the subcellular localization of DNER by the sorting motifs. To examine which sites are required for the regulation of the subcellular localization of DNER, we transfected Neuro-2A neuroblastoma cells with various DNER constructs listed in Fig. 1 . As in the case of COS-7 transfectants, the full-length form of DNER (DHA) showed perinuclear cytoplasmic localization (Fig. 8A) , and DdI exhibited cell surface distribution (Fig. 8E) . While most of the mock-transfected and DHA-expressing Neuro-2A cells showed a rounded cell shape, a substantial portion (20 to 30%) of the DdI-expressing cells displayed thick cell processes, suggesting that the cell surface expression of DNER is involved in the regulation of the morphogenesis of neurons (Fig. 8E) .
When Neuro-2A cells were transfected with the D-Y677A or D-Y681A constructs, in which the tyrosine-based motif is destroyed, these DNER mutants showed normal perinuclear cytoplasmic localization, like that of DHA (Fig. 8F) (A) Lysates of the P15 mouse cerebella were subjected to immunoprecipitation using anti-DNER or control IgG. The precipitated proteins were analyzed by Western blotting using anti-DNER or antiphosphotyrosine antibodies (anti-pTyr). The arrowhead indicates the band of tyrosine-phosphorylated DNER. Several bands were nonspecifically precipitated and stained by antiphosphotyrosine antibody (arrows). (B) COS-7 transfectants expressing DHA were treated with 100 M sodium vanadate (VA) for 6 h, and then the cell lysates were subjected to immunoprecipitation using anti-HA or control IgG. The immunoprecipitates were analyzed by Western blotting with anti-HA or antiphosphotyrosine antibodies. The tyrosine-phosphorylated DNER was often detected as a broad band larger than the band of nonphosphorylated DNER, probably because there were differentially phosphorylated DNER proteins. (C) COS-7 transfectants expressing DHA were treated with 100 M sodium vanadate for 12 h, and the cell lysates were subjected to immunoprecipitation using anti-HA antibod- (Fig. 8F) . In contrast, D-Y718stop, which lacks the C-terminal 20 amino acids, showed increased cell surface expression (3.9% Ϯ 1.9% for DHA versus 41.6% Ϯ 21.5% for D-Y718stop) (Fig. 8B, C, and F) , suggesting that the C-terminal portion plays major roles in the internalization of DNER in this expression system. However, the function of the tyrosine-based motif became apparent when a mutation of this motif was introduced into the D-Y718stop construct. In contrast to the D-Y677A and D-Y718stop mutants, the D-Y677A/Y718stop mutant displayed almost complete cell surface localization (88.5% Ϯ 5.7% for D-Y677A/Y718stop) (Fig. 8F) . Moreover, the D-Y677A/ Y718A/Y721A and D-Y677A/Y681A/Y718A/Y721A mutants showed fairly increased cell surface expression compared with DHA and the D-Y718A/Y721A mutant (Fig. 8F) , consistent with the observation that sodium vanadate treatments increased the cell surface expression of DHA (Fig. 7) . Like DdI-expressing cells, the Neuro-2A cells expressing D-Y677A/Y718stop often showed thick processes (Fig. 8D ). These observations indicated that the tyrosine residues in the cytoplasmic domain of DNER play important roles in the determination of the subcellular localization of this protein.
Next, we transfected the DdI construct into Purkinje cells by using an organotypic slice culture system of cerebellum (Fig.  8G to L) . While most Purkinje cells had a single primary dendrite in the control culture ( Fig. 8G and H) , most DdIexpressing Purkinje cells had two or more primary dendrites ( Fig. 8I and J) . This phenotype is very similar to that observed when PTP-PTN signaling was inhibited (43) , suggesting that this signaling system regulates the subcellular localization of DNER.
PTN regulates the endocytosis of DNER in Neuro-2A cells. DNER is actively endocytosed from the plasma membrane and delivered to the EEA1-positive early endosomes, and this sorting is thought to be mediated by the tyrosine-based signal in DNER (7). The above experiments indicated that a tyrosine residue in this sorting signal is phosphorylated (Fig. 6) and that the inhibition of tyrosine phosphatase activities by sodium vanadate inhibited the endocytosis of DNER in the COS-7 cells coexpressing DNER and PTP (Fig. 7) . On the other hand, the tyrosine phosphatase activity of PTP is inactivated by PTN stimulation through receptor dimerization (10, 29) . Therefore, we hypothesized that PTN-PTP signaling regulates the endocytosis of DNER by controlling the tyrosine phosphorylation levels of this protein. To test this possibility, we performed experiments using Neuro-2A cells, which express endogenous PTP-A and -B but not DNER, as revealed by reverse transcription-PCR analysis (data not shown). The Neuro-2A cells were transfected with DHA or D-Y718stop constructs, and the cell surface-expressed proteins were labeled with anti-HA antibody. The cells were incubated for various times in the presence or absence of PTN, and the DNER proteins that were internalized or remained on the cell surface were visualized using fluorescently labeled secondary antibodies. We classified the DNER localization into three types: type I, intracellular localization; type II, cell surface and intracellular localization; and type III, cell surface localization (Fig. 9B) .
In the control culture, antibody-labeled DHA proteins were rapidly internalized, and internalization of DHA was only slightly delayed even in the presence of PTN (Fig. 9A, a, c, and  e) . The time required for 50% of the cells to show type I FIG. 7 . Regulation of the subcellular localization of DNER by tyrosine phosphorylation. (A) COS-7 transfectants expressing both DHA and PTP-B were cultured in the presence (d to f) or absence (a to c) of 100 M sodium vanadate (VA) for 12 h. The cells were permeabilized and stained with anti-HA (b and e; red) and anti-PTP (a and d; green), which recognizes the D2 domain of PTP. The merged images are shown in subpanels c and f. In the presence of sodium vanadate, PTP-B and DHA showed colocalization on the cell surface (f). In the absence of sodium vanadate, PTP immunoreactivity was detected on the cell surface and in the cytoplasm (a), and DNER immunoreactivity was accumulated around the nucleus (b). In this case, the colocalization of the two immunoreactivities around the nucleus was not remarkable in contrast to the results shown in Fig. 4 . In Fig. 4 , the cells were doubly stained with anti-HA and anti-6B4PG, which recognizes the extracellular region of PTP. This suggests that the D2 domain of PTP is proteolytically processed or modified during intracellular trafficking. The cell peripheries are indicated by arrows. Bar, 20 m. (B) COS-7 transfectants expressing DHA and PTP were cultured in the presence or absence of 100 M sodium vanadate for 12 h, and cell surface proteins were biotinylated at 4°C. The biotinylated proteins were separated with streptavidin agarose and analyzed by Western blotting using monoclonal anti-HA antibody to detect cell surface DHA (Strep). The expression levels of DHA were examined by Western blot analysis of the cell lysates using anti-HA (Lysate). Treatment with sodium vanadate increased the cell surface expression of DHA. Numbers at right are molecular masses in kilodaltons. http://mcb.asm.org/ localization (T 1/2 ) was 2.9 Ϯ 0.6 min for the control culture. In the presence of PTN, T 1/2 was 4.7 Ϯ 0.5 min (P Ͻ 0.05 versus control; t test). The data in Fig. 8 indicated that the C-terminal portion plays a major role in the endocytosis of DNER in Neuro-2A cells. Although Tyr-718 and/or Tyr-721 could be tyrosine phosphorylated ( Fig. 1 and Fig. 6 ), their phosphorylation might not interfere with the function of the C-terminal motif. On the other hand, the tyrosine-based sorting motif could be directly phosphorylated, and therefore, its function is expected to be regulated by phosphorylation. Thus, we next analyzed Neuro-2A cells expressing the D-Y718stop mutant which has only the tyrosine-based sorting motif (Fig. 1) . D-Y718stop mutant proteins took a longer time (T 1/2 ϭ 7.3 Ϯ 0.5 min) to be internalized than did DHA (Fig. 9A, b, d , and f). In addition, PTN significantly decreased the rate of internalization of D-Y718stop proteins (T 1/2 ϭ 11.0 Ϯ 0.5 min) (P Ͻ 0.01 versus control; t test) (Fig. 9A, b and d) , suggesting that PTN suppressed the function of the tyrosine-based sorting motif by inducing the tyrosine phosphorylation of this motif. In order to confirm that PTN stimulates the tyrosine phosphorylation of DNER, Neuro-2A cells expressing DHA were treated with PTN-coated beads for various periods (Fig. 9C) . (Fig. 8) . These mutant DNER proteins were accumulated on the cell surface, and their endocytosis was suppressed, suggesting that blockage of DNER endocytosis leads to morphological changes of cells, possibly including neuritogenesis. Thus, next we examined the effects of PTN on the neuritogenesis of Neuro-2A cells expressing DHA because PTN suppressed the endocytosis of this protein (Fig. 9) .
Neuro-2A cells differentiate and extend neurites in response to retinoic acid (30). As described above, Neuro-2A cells expressed PTP but not DNER. Western blotting indicated that the treatment of Neuro-2A cells with 40 M retinoic acid for 24 h did not alter the expression levels of these proteins (data not shown). We first cultured Neuro-2A cells on PTN-coated plates in the presence of retinoic acid (Fig. 10) . Instead of adding PTN to the culture medium, we used substrate-bound PTN because the effects of soluble PTN were transient and low (Fig. 9) . Although PTN induced neurite outgrowth of cerebral neurons (18, 36) , this growth factor did not influence the retinoic acid-induced neuritogenesis of Neuro-2A cells (Fig. 10A , B, E, and F). Unexpectedly, when DHA was expressed, retinoic acid-induced neurite extension was remarkably suppressed in Neuro-2A cells on the uncoated plates, and the DHA-expressing cells displayed rounded morphology, like the cells cultured in the absence of retinoic acid (Fig. 10C) . In contrast, on the PTN-coated plates, Neuro-2A cells expressing DHA extended neurites in response to retinoic acid, like mock-transfected cells (Fig. 10D , E, and F), indicating that PTN inactivated the DNER activity in Neuro-2A cells.
DISCUSSION
In this study, we demonstrated that PTP associates with DNER and regulates the endocytic trafficking of this protein.
Recently, it has been recognized that endocytic and exocytic processes play important roles in neurite extension and retraction (41) . There are dynamic recycling endosomes in the growth cones, dendrites, and axons regulating the membrane flow in these cellular compartments (5). Our immunohistochemical studies indicated that PTP and DNER were partly colocalized at the patchy structures in the dendritic shafts of Purkinje cells (Fig. 3) . Further immunoelectron microscopic analysis suggested that these patchy structures correspond to various-sized cytoplasmic vesicles and the plasma membrane. The Purkinje cell plasma membrane facing the Bergmann glial processes often showed PTP and DNER immunoreactivities. Previous studies indicated that DNER interacted with coatassociated protein complex AP-1, which mediates polarized targeting of proteins in clathrin-coated transport vesicles (7) . It has been suggested that AP-1 recognizes the sorting motifs in the DNER cytoplasmic tail and targets this protein to the somatodendritic compartment through the trans-Golgi network/endosomal system. In addition, it was also proposed that another adaptor protein complex, AP-2, is involved in the clathrin-dependent endocytosis of DNER from the plasma membrane (7). These AP complexes recognize tyrosine-based and dileucine type sorting motifs (6) . Both motifs are present in the cytoplasmic region of DNER (Fig. 1) , and thus, the DNER-immunoreactive vesicles might correspond to these clathrin-coated vesicles. Classical studies by Altman (1) indicated that there are many coated vesicles in the dendrites of developing Purkinje cells, and PTP and DNER might be transported by such vesicles, regulating the dynamic presentation of these proteins on the plasma membrane. At present, immunogold labeling has not been successful because of the low titer of the anti-PTP monoclonal antibody. However, further double-immunogold labeling experiments at the electron microscopic level are needed to confirm that both proteins are localized at coated vesicles.
Previously, we reported that inhibition of PTP-PTN signaling resulted in the aberrant morphogenesis of cerebellar Purkinje cell dendrites (43) . Most of the mature Purkinje cells have only one primary dendrite, which extends toward the pial surface and extensively branches in the molecular layer. However, in the presence of various inhibitors of PTP-PTN signaling, Purkinje cells with multiple and disoriented primary dendrites increased in the organotypic slice culture system of the rat cerebellum (43) . Forced expression of DdI in the Purkinje cells also induced similar abnormal morphogenesis of Purkinje cell dendrites (Fig. 8) . Because of the lack of endocytic sorting signals, this DNER mutant accumulates on the plasma membrane, suggesting that continuous endocytosis of this membrane protein is necessary for the normal morphogenesis of Purkinje cells. Similar phenomena were observed for Neuro-2A transfectants (Fig. 8) . Neuro-2A cells expressing DdI extended thick processes, although overexpression of the full-length DNER construct, DHA, resulted in no morphological changes. While DdI was accumulated on the plasma membrane, most of the DHA was internalized and there was little DHA protein on the plasma membrane. Thus, overaccumulation of DNER on the plasma membrane might promote the extension and/or stabilization of odd neurites. Inhibitors of PTP-PTN signaling might disturb the endocytosis of DNER in Purkinje cells, leading to the accumulation of DNER on the plasma membrane and to the aberrant morphogenesis of dendrites.
Multiple tyrosine residues in and around the tyrosine-based and dileucine type sorting motifs of the DNER cytoplasmic tail were phosphorylated (Fig. 6 ). Sodium vanadate inhibited the endocytosis of DNER in COS-7 transfectants (Fig. 7) , suggesting that the tyrosine phosphorylation of the DNER cytoplasmic region sterically hinders its association with AP complexes. A similar mechanism was reported for a cell adhesion molecule, L1, by Schaefer et al. (38) . They demonstrated that tyrosine phosphorylation at the tyrosine-based sorting motif of the cytoplasmic region of L1 blocked its interaction with the 2 subunit of AP-2, which led to the inhibition of the internalization of this molecule. Tyrosine-phosphorylated DNER was dephosphorylated by the PTP catalytic domain. On the other hand, accumulating evidences demonstrated that PTN induces dimerization of PTP, resulting in the inactivation of its phosphatase activity (10, 29) . Therefore, we speculate that PTP constitutively dephosphorylates DNER, and PTN-induced inactivation of its phosphatase activity leads to the increased tyrosine phosphorylation of DNER and the suppression of its endocytosis. In fact, PTN stimulation of Neuro-2A transfectants increased tyrosine phosphorylation of DNER and suppressed the endocytosis of this protein (Fig. 9) .
Recently, Kotani et al. (15) produced transgenic mice expressing a constitutively active form of neuronal src (n-src) kinase selectively in Purkinje cells. The Purkinje cells expressing active n-src showed multiple dendritic shafts extending in nonpolarized directions. This phenotype of Purkinje cells is very similar to that observed when PTP-PTN signaling was inhibited (43) or DdI was expressed in Purkinje cells (see above). Active n-src might constantly phosphorylate DNER and induce accumulation of this protein on Purkinje cell surface. Several reports suggested that src kinase is involved in PTN-PTP signaling (34, 35) . In human endothelial cells, PTN/ HARP activated src kinase and focal adhesion kinase through PTP, stimulating the migration and tube formation (34) . Thus, there is also a possibility that PTN-PTP signaling indirectly promotes the tyrosine phosphorylation of DNER through the activation of the src kinase pathway. Further studies are needed to clarify this point.
Recently, it was found that DNER acts as a ligand of Notch receptor and regulates the cell-cell interaction between Pur-kinje cells and Bergmann glia (8) . Bergmann glia strongly express Notch1, which is activated by DNER on Purkinje cells. DNER promoted the process formation of Bergmann glia through Deltex-dependent Notch signaling in vitro. The Bergmann glia in DNER-deficient mice showed retarded formation of radial fibers, reduced expression of GLAST, and ectopic localization in the molecular layer (44) . At present, it remains to be determined whether PTP signaling affects the Notch pathway in the cerebellar cortex. However, our slice culture experiments indicated that inhibition of PTP-PTN signaling led to the reduced expression of GLAST in Bergmann glia (43) , suggesting that at least a part of this signaling system is coupled with the DNER-Notch pathway.
It is well known that Notch signaling controls cell fate and various differentiation processes, including neurite outgrowth (3, 4, 37, 39) . In this study, we observed that forced expression of DNER in Neuro-2A cells suppressed the retinoic-acid-induced neurite extension (Fig. 10) . Because Neuro-2A cells express low levels of Notch1 (9), it might be that DNER activated the Notch1 pathway and inhibited the differentiation of this neuroblastoma by cis interaction. However, there is also a possibility that DNER associated with proteins other than Notch and suppressed the differentiation of Neuro-2A cells. PTN reversed this inhibitory activity of DNER and allowed neurite extension induced by retinoic acid, suggesting that endocytosis of DNER is required for the suppression of the differentiation of Neuro-2A cells.
The binding of PTN with phosphacan depends on both the chondroitin sulfate and protein portions of this proteoglycan, and removal of chondroitin sulfate resulted in marked decrease of the binding affinity (22, 25, 26) . Phosphacan and PTN are deposited between the Purkinje cell surface and the processes of Bergmann glia, and chondroitinase ABC digestion of cerebellar slices remarkably reduced the PTN content in the tissue (40) . In this study, we found that phosphacan did not bind with DdI on COS-7 transfectants, suggesting that phosphacan does not interfere with the PTP-DNER or DNERNotch binding. Instead, phosphacan might serve as a reservoir of PTN secreted by Bergmann glia (25, 27, 43, 45) .
Both PTP-A and -B isoforms are synthesized as chondroitin sulfate proteoglycans. PTP-B lacks a large part of the chondroitin sulfate attachment region (32) , suggesting that the affinity of PTP-B for PTN is weaker than that of PTP-A because of the difference in the number of chondroitin sulfate chains attached to the core proteins. Thus, the strength of PTN-PTP signaling could be regulated by the relative expression levels of PTP-A and -B. At P6, comparable amounts of PTP-A and -B were detected in the cerebellum; however, after that, the expression of PTP-A remarkably decreased ( Fig. 2A) . Before P7, many Purkinje cells have short multiple primary dendrites (40) . Thereafter, Purkinje cells vigorously extend dendrites till P20, and most of them have only one primary dendrite after P16 (40) . So, strong PTN-PTP signaling mediated by PTP-A during the early developmental period might allow extension of multiple dendrites by the efficient inhibition of endocytosis of DNER.
Morphological differentiation of Purkinje cells was significantly retarded in the DNER-deficient mice until the second postnatal week; however, this hypoplasia was recovered by the third postnatal week (44) . On the other hand, it has been reported that mutant mice deficient in PTP showed no gross morphological abnormality in the adult nervous system (11) . However, detailed analysis demonstrated that the morphological differentiation of Purkinje cells was retarded in the PTPdeficient mice until P8 (unpublished observation). These observations suggest that the loss of DNER and PTP can be compensated for by the other signaling molecules. For example, PTP deficiency might be compensated for by syndecan 3. Syndecan 3 uses PTN as a ligand, and its function and signal transduction mechanism share many common characteristics with those of PTP (2, 13). It will be interesting to analyze the development of Purkinje cells in the mice that are doubly mutant for these genes.
Although it has been suggested that chondroitin sulfate proteoglycans play important roles in the neuron-glia interaction, little is known about the molecular mechanism. This study suggested that PTP-PTN signaling regulates Purkinje cellBergmann glia interaction by modulating the DNER function. PTP-PTN-DNER signaling is a useful system to elucidate the mechanism of chondroitin sulfate proteoglycan-mediated neuron-glia interaction.
